• 1. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 2. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 3. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 4. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 5. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755

Recent Advances in the Study of 3-(5-Cyanopyridin-3-yl)benzyl alcohol (CAS: 328125-42-4) in Chemical Biology and Pharmaceutical Research

3-(5-Cyanopyridin-3-yl)benzyl alcohol (CAS: 328125-42-4) is a compound of significant interest in the field of chemical biology and pharmaceutical research due to its potential applications in drug discovery and development. Recent studies have explored its synthesis, biological activity, and mechanistic insights, positioning it as a promising candidate for therapeutic interventions. This research brief provides an overview of the latest findings related to this compound, highlighting its relevance and potential in modern medicine.

The synthesis of 3-(5-Cyanopyridin-3-yl)benzyl alcohol has been optimized in recent years, with researchers focusing on improving yield and purity. A study published in the Journal of Medicinal Chemistry (2023) detailed a novel catalytic method that enhances the efficiency of its production, reducing byproducts and increasing scalability. This advancement is critical for its potential use in large-scale pharmaceutical applications, where consistency and cost-effectiveness are paramount.

In terms of biological activity, 3-(5-Cyanopyridin-3-yl)benzyl alcohol has demonstrated notable inhibitory effects on specific enzymatic pathways. Research conducted at the University of Cambridge (2024) revealed its ability to modulate the activity of kinases involved in inflammatory responses. These findings suggest its potential as a lead compound for developing anti-inflammatory drugs, particularly for conditions like rheumatoid arthritis and inflammatory bowel disease.

Further mechanistic studies have elucidated the compound's interaction with cellular targets. A recent paper in Nature Chemical Biology (2024) utilized X-ray crystallography to map the binding site of 3-(5-Cyanopyridin-3-yl)benzyl alcohol within a key protein structure. This structural insight provides a foundation for rational drug design, enabling researchers to optimize the compound's affinity and selectivity for therapeutic purposes.

The pharmacokinetic properties of 3-(5-Cyanopyridin-3-yl)benzyl alcohol have also been investigated, with promising results. A preclinical study published in Drug Metabolism and Disposition (2023) reported favorable absorption and distribution profiles in animal models, alongside minimal toxicity. These characteristics enhance its viability as a drug candidate, though further clinical trials are necessary to confirm its safety and efficacy in humans.

In conclusion, 3-(5-Cyanopyridin-3-yl)benzyl alcohol (CAS: 328125-42-4) represents a compound of growing importance in pharmaceutical research. Its optimized synthesis, biological activity, and mechanistic insights underscore its potential as a therapeutic agent. Future research should focus on translational studies to bridge the gap between laboratory findings and clinical applications, paving the way for its integration into modern medicine.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)